380 related articles for article (PubMed ID: 30391801)
21. Extracellular vesicles derived from immortalized human natural killer cell line NK3.3 as a novel therapeutic for multiple myeloma.
Matchett EC; Kornbluth J
Front Immunol; 2023; 14():1265101. PubMed ID: 37818374
[TBL] [Abstract][Full Text] [Related]
22. Adipose-derived mesenchymal stem cells and extracellular vesicles confer antitumor activity in preclinical treatment of breast cancer.
Li T; Zhou X; Wang J; Liu Z; Han S; Wan L; Sun X; Chen H
Pharmacol Res; 2020 Jul; 157():104843. PubMed ID: 32360582
[TBL] [Abstract][Full Text] [Related]
23. Natural Killer Cell-Derived Extracellular Vesicles as a Promising Immunotherapeutic Strategy for Cancer: A Systematic Review.
Chan AML; Cheah JM; Lokanathan Y; Ng MH; Law JX
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835438
[TBL] [Abstract][Full Text] [Related]
24. ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma.
Zhang C; Burger MC; Jennewein L; Genßler S; Schönfeld K; Zeiner P; Hattingen E; Harter PN; Mittelbronn M; Tonn T; Steinbach JP; Wels WS
J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26640245
[TBL] [Abstract][Full Text] [Related]
25. Immune Cell-Derived Extracellular Vesicles - New Strategies in Cancer Immunotherapy.
Yang P; Peng Y; Feng Y; Xu Z; Feng P; Cao J; Chen Y; Chen X; Cao X; Yang Y; Jie J
Front Immunol; 2021; 12():771551. PubMed ID: 34956197
[TBL] [Abstract][Full Text] [Related]
26. Discovery of a novel natural killer cell line with distinct immunostimulatory and proliferative potential as an alternative platform for cancer immunotherapy.
Yang HG; Kang MC; Kim TY; Hwang I; Jin HT; Sung YC; Eom KS; Kim SW
J Immunother Cancer; 2019 May; 7(1):138. PubMed ID: 31126350
[TBL] [Abstract][Full Text] [Related]
27. CD24 targeting bi-specific antibody that simultaneously stimulates NKG2D enhances the efficacy of cancer immunotherapy.
Han Y; Sun F; Zhang X; Wang T; Jiang J; Cai J; Gao Q; Hezam K; Liu Y; Xie J; Wang M; Zhang J
J Cancer Res Clin Oncol; 2019 May; 145(5):1179-1190. PubMed ID: 30778749
[TBL] [Abstract][Full Text] [Related]
28. hIL-15 gene-modified human natural killer cells (NKL-IL15) augments the anti-human hepatocellular carcinoma effect in vivo.
Jiang W; Zhang C; Tian Z; Zhang J
Immunobiology; 2014 Jul; 219(7):547-53. PubMed ID: 24721706
[TBL] [Abstract][Full Text] [Related]
29. A clinically relevant large-scale biomanufacturing workflow to produce natural killer cells and natural killer cell-derived extracellular vesicles for cancer immunotherapy.
St-Denis-Bissonnette F; Cummings SE; Qiu S; Stalker A; Muradia G; Mehic J; Mediratta K; Kaczmarek S; Burger D; Lee SH; Wang L; Lavoie JR
J Extracell Vesicles; 2023 Dec; 12(12):e12387. PubMed ID: 38054534
[TBL] [Abstract][Full Text] [Related]
30. Combined Role of Interleukin-15 Stimulated Natural Killer Cell-Derived Extracellular Vesicles and Carboplatin in Osimertinib-Resistant H1975 Lung Cancer Cells with EGFR Mutations.
Nathani A; Sun L; Khan I; Aare M; Bagde A; Li Y; Singh M
Pharmaceutics; 2024 Jan; 16(1):. PubMed ID: 38258094
[TBL] [Abstract][Full Text] [Related]
31. Immunological characterization of glioblastoma cells for immunotherapy.
Jung TY; Choi YD; Kim YH; Lee JJ; Kim HS; Kim JS; Kim SK; Jung S; Cho D
Anticancer Res; 2013 Jun; 33(6):2525-33. PubMed ID: 23749904
[TBL] [Abstract][Full Text] [Related]
32. Large-scale isolation and cytotoxicity of extracellular vesicles derived from activated human natural killer cells.
Jong AY; Wu CH; Li J; Sun J; Fabbri M; Wayne AS; Seeger RC
J Extracell Vesicles; 2017; 6(1):1294368. PubMed ID: 28326171
[TBL] [Abstract][Full Text] [Related]
33. Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain.
Lee SJ; Kang WY; Yoon Y; Jin JY; Song HJ; Her JH; Kang SM; Hwang YK; Kang KJ; Joo KM; Nam DH
BMC Cancer; 2015 Dec; 15():1011. PubMed ID: 26704632
[TBL] [Abstract][Full Text] [Related]
34. Radioiodine labeling and in vivo trafficking of extracellular vesicles.
Hong CM; Gangadaran P; Oh JM; Rajendran RL; Gopal A; Zhu L; Ahn BC
Sci Rep; 2021 Mar; 11(1):5041. PubMed ID: 33658566
[TBL] [Abstract][Full Text] [Related]
35. Cancer extracellular vesicles as novel regulators of NK cell response.
Soriani A; Vulpis E; Cuollo L; Santoni A; Zingoni A
Cytokine Growth Factor Rev; 2020 Feb; 51():19-26. PubMed ID: 31837917
[TBL] [Abstract][Full Text] [Related]
36. α-Pinene Enhances the Anticancer Activity of Natural Killer Cells via ERK/AKT Pathway.
Jo H; Cha B; Kim H; Brito S; Kwak BM; Kim ST; Bin BH; Lee MG
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33440866
[TBL] [Abstract][Full Text] [Related]
37. Tumor-Derived Extracellular Vesicles Inhibit Natural Killer Cell Function in Pancreatic Cancer.
Zhao J; Schlößer HA; Wang Z; Qin J; Li J; Popp F; Popp MC; Alakus H; Chon SH; Hansen HP; Neiss WF; Jauch KW; Bruns CJ; Zhao Y
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31234517
[TBL] [Abstract][Full Text] [Related]
38. Tumor growth impedes natural-killer-cell maturation in the bone marrow.
Richards JO; Chang X; Blaser BW; Caligiuri MA; Zheng P; Liu Y
Blood; 2006 Jul; 108(1):246-52. PubMed ID: 16556890
[TBL] [Abstract][Full Text] [Related]
39. Cationic Nanoparticle-Mediated Activation of Natural Killer Cells for Effective Cancer Immunotherapy.
Kim KS; Han JH; Choi SH; Jung HY; Park JD; An HJ; Kim SE; Kim DH; Doh J; Han DK; Kim IH; Park W; Park KS
ACS Appl Mater Interfaces; 2020 Dec; 12(51):56731-56740. PubMed ID: 33290037
[TBL] [Abstract][Full Text] [Related]
40. Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells.
Boerman GH; van Ostaijen-ten Dam MM; Kraal KC; Santos SJ; Ball LM; Lankester AC; Schilham MW; Egeler RM; van Tol MJ
Cancer Immunol Immunother; 2015 May; 64(5):573-83. PubMed ID: 25854581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
